This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Skip to content

new formula

A board to discuss the Multiple Sclerosis modifying drug Copaxone
Post a reply

new formula

Postby scorpion » Sat Jun 05, 2010 5:23 pm

Teva announces positive results from a study assessing a new formulation of Copaxone.

<shortened url>
User avatar
scorpion
Family Elder
 
Posts: 1323
Joined: Wed Nov 05, 2008 3:00 pm
Top

Advertisement

Postby DizzyDean » Fri Jun 18, 2010 3:34 pm

The text seems to contradict the conclusion of the study - 12.5% vs 18.1% for those with the new formulation suggests a relative risk INCREASE of nearly 50% for tolerability problems with the new formulation.

A typo? Anybody have a link to the original paper?

Adverse events were reported by 12.5 percent of patients when injecting 20mg/1.0mL and by 18.1 percent of patients when injecting 20mg/0.5mL.
User avatar
DizzyDean
Family Member
 
Posts: 45
Joined: Fri Jun 01, 2007 2:00 pm
Top
Post a reply

Return to Copaxone

Who is online

Users browsing this forum: No registered users

Advertise on the premier multiple sclerosis forum

Read hundreds of personal Multiple Sclerosis stories on Experience Project. Experience Project is an anonymous community where people connect through their life experiences, made by the same people who built This is MS. With over 30 million personal stories about every possible life experience, you can quickly find people like you!

Interesting: Secret Confessions | Dream Meanings | Ask Questions, Get Answers